Smart Solutions for Better and Faster Tissue Repair
Bringing hope and healing to chronic wound patients through innovative bioink technology
What is a Bioink?
Bioink is a biocompatible material that supports the body’s ability to heal and regenerate tissue.
By combining multiple methods, we aim to provide effective, patient-centered treatments that accelerate healing and improve outcomes for chronic wounds.
At Smart Tissues, we utilize bioinks in several innovative ways, including producing advanced wound-healing membranes and employing bioprinting techniques to create tailored regenerative solutions.
What is a Chronic Wound?
Chronic Wounds: A Persistent Challenge
Chronic wounds are injuries that fail to heal within a normal timeframe—often lingering for weeks, months, or even years. They commonly stem from underlying conditions like diabetes, vascular disease, pressure ulcers, or traumatic injury. Unlike acute wounds, they stall in the healing process, increasing the risk of pain, infection, and, in severe cases, amputation.
At Smart Tissues, we offer the best solution for fast - riskless chronic wound healing. we recognize the deep and lasting impact chronic wounds have on patients—not only physically, but emotionally and socially. For many, conventional treatments provide little relief, leaving them with limited options and growing risks.
Diabetic Foot Ulcers (DFUs)
A chronic wound that often ends in amputation or death
20%
19-34%
30%
65%
+18.6M
of infected DFUs results in Amputation
of diabetic patients will develop DFU
of DFU patients pass away within 5 years
of cured cases have recurrent ulcers
new DFU diagnosis globally per year
At Smart Tissues, we are addressing this urgent medical need with a unique solution that offers the perfect balance between tissue regeneration and antibacterial protection. Our technology is designed to accelerate healing, reduce infection risk, and ultimately prevent limb loss—bringing new hope to millions living with DFUs worldwide.
Our Objective
Our mission is to deliver effective solutions that prevent infections and reduce the need for amputations—especially for the more than 500 million people worldwide living with diabetes who are vulnerable to diabetic foot ulcers.
By combining advanced regenerative therapies, natural biomaterials, and cutting-edge biofabrication technologies, we aim to activate the body’s natural healing response.
Our approach promotes tissue regeneration, lowers infection risk, and accelerates recovery—offering new hope for wounds once considered untreatable.
Through innovation and compassion, Smart Tissues is dedicated to improving lives—helping patients heal faster, regain mobility, and reclaim quality of life.
